Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study

被引:0
作者
C.-Y. Lai
T.-Y. Yang
C.-L. Lin
C.-H. Kao
机构
[1] China Medical University Hospital,Department of Emergency Medicine
[2] China Medical University,Molecular and Genomic Epidemiology Center, China Medical University Hospital
[3] Changhua Christian Hospital,Division of Nephrology, Department of Internal Medicine
[4] China Medical University Hospital,Management Office for Health Data
[5] China Medical University,College of Medicine
[6] China Medical University Hospital,Department of Nuclear Medicine and PET Center
[7] China Medical University,Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine
来源
European Journal of Clinical Microbiology & Infectious Diseases | 2015年 / 34卷
关键词
Chronic Obstructive Pulmonary Disease; Acute Coronary Syndrome; National Health Insurance Research Database; Crude Hazard Ratio; Severe Coronary Heart Disease;
D O I
暂无
中图分类号
学科分类号
摘要
Helicobacter pylori infection (HPI) imposes substantial social costs and is of major etiological importance in peptic ulcer disease, gastric cancer, and accelerated cardiovascular diseases. This study determined the risk of acute coronary syndrome (ACS) associated with HPI in a nationwide retrospective cohort study. By using the Taiwan National Health Insurance Research Database (NHIRD), we identified patients diagnosed with HPI from 1998 to 2010. In addition, we randomly selected non-HPI controls frequency-matched by age, sex, and index year from the general population free of HPI. The risk of ACS was analyzed using Cox proportional hazards regression models in which sex, age, and comorbidities were included as variables. We identified 17,075 participants for the HPI group and selected 68,300 participants for the comparison group. The incidence rates were increased in the patients in the HPI group compared with those in the comparison group. Overall, the HPI patients exhibited a 1.93-fold high crude hazard ratio for ACS, and a 1.48-fold adjusted hazard ratio after age, sex, and comorbidities were adjusted. However, the overall adjusted hazard ratio of ACS increased with increasing age with a 3.11 to 8.24 adjusted hazard ratio among the various age groups. Several comorbidities, such as diabetes, hyperlipidemia, and COPD exhibited synergistic effects for ACS risk. We determined a significant association between ACS and comorbidities and provide evidence to encourage clinicians to observe ACS-related comorbidities.
引用
收藏
页码:69 / 74
页数:5
相关论文
共 143 条
[21]  
Lin TH(2009)Helicobacter pylori infection and inflammation: implication for the pathophysiology of diabetes and coronary heart disease in Asian Indians J Life Sci 1 45-1920
[22]  
Huang CH(2003)Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals Infect Immun 71 1755-586
[23]  
Lee KT(2004)Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity J Infect Dis 189 1914-1256
[24]  
Wang WM(2007)Host response to Helicobacter pylori infection before initiation of the adaptive immune response FEMS Immunol Med Microbiol 51 577-135
[25]  
Hara K(2009)Helicobacter pylori seropositivity in patients with acute coronary syndromes Dig Dis Sci 54 1253-706
[26]  
Morita Y(2012)Prognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study Cardiovasc J Afr 23 131-402
[27]  
Kamihata H(2006)Association of Helicobacter pylori infection with cardiac syndrome X Singapore Med J 47 704-508
[28]  
Iwasaka T(2002)Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina Dig Liver Dis 34 398-461
[29]  
Takahashi H(2008)Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa Eur J Cardiovasc Prev Rehabil 15 503-undefined
[30]  
Mair J(2012)Helicobacter pylori infection is identified as a cardiovascular risk factor in central Africans Vasc Health Risk Manag 6 455-undefined